Artivion (AORT) Gains from Investment Securities (2017 - 2026)
Artivion (AORT) posted Gains from Investment Securities of $1.7 million for Q1 2026, down 67.23% on a QoQ basis from $5.3 million in Q4 2025, and up 161.48% year-over-year from $665432.4 in Q1 2025.
Artivion (AORT) Gains from Investment Securities (2017 - 2026) Analysis & Trends
Artivion's Gains from Investment Securities history runs 10 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- Quarterly Gains from Investment Securities rose 161.48% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.2 million (up 237.47% YoY) and the FY2025 annual result came in at $7.7 million, up 169.94% from the prior year.
- Gains from Investment Securities was $1.7 million for Q1 2026 at Artivion, down from $5.3 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $10.9 million in Q2 2023 and bottomed at -$17.5 million in Q1 2024.
- A 5-year average of $758823.5 and a median of $1.7 million in 2026 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities soared 1450.0% — and 2024, when it slumped 463.96%.
- Artivion's Gains from Investment Securities stood at -$4.4 million in 2022, then jumped by 136.14% to $1.6 million in 2023, then fell by 27.04% to $1.2 million in 2024, then soared by 357.76% to $5.3 million in 2025, then slumped by 67.23% to $1.7 million in 2026.
- Business Quant data shows AORT's Gains from Investment Securities at $1.7 million in Q1 2026, $5.3 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn |
| 10 | Artivion | 1.25 Bn | 1.20 Bn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.74 Mn |
| Mar 31, 2026 | 1.74 Mn |
| Dec 31, 2025 | 5.31 Mn |
| Dec 31, 2025 | 5.31 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | -2.83 Mn |
| Mar 31, 2025 | -2.83 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | -17.47 Mn |
| Mar 31, 2024 | -17.47 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Dec 31, 2023 | 1.59 Mn |